Editor-in-Chief of the European Journal in Medicinal Chemistry (EJMECH). This journal publish paper from all over the world. Actually approximately one third of all accepted papers are coming from China. The impact factor of EJMECH has regularly increased in the recent years and now reaches 3.9.
Main research interest:
- Kinase inhibitors and in particular cyclin-dependent kinase inhibitors.
- Compounds acting on protein misfolding.
In these two fields, chemical biology approaches are performed. Probes are prepared, from the active compounds, and used to uncover their molecular mechanism(s) of action.
Contact : email@example.com